Cargando…
Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19), which has spread worldwide since it was first identified in Wuhan, China, at the end of 2019. With the global transmission of the virus, a large number of SARS-CoV-2 variants h...
Autores principales: | Jia, Zaixing, Gong, Wenping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111046/ https://www.ncbi.nlm.nih.gov/pubmed/33975397 http://dx.doi.org/10.3346/jkms.2021.36.e124 |
Ejemplares similares
-
Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development
por: Singh, Praveen Kumar, et al.
Publicado: (2020) -
Mutations and Evolution of the SARS-CoV-2 Spike Protein
por: Magazine, Nicholas, et al.
Publicado: (2022) -
Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV-2
por: Paul, Debadrita, et al.
Publicado: (2021) -
Stability and expression of SARS-CoV-2 spike-protein mutations
por: Bæk, Kristoffer T., et al.
Publicado: (2022) -
SARS-CoV-2 variants – Evolution, spike protein, and vaccines
por: Chen, Kai-Wei K., et al.
Publicado: (2022)